Although deregulation of MYC, a well-known oncogene located in proximity to BOP1, has been considered as a late progression event in MM, an association between MYC overexpression and 8q24 gains at relapse was not found in this set of samples. This evidence concerns the gene BOP1 and Miyoshi myopathy.